Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Oliveri

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Progress in Clinical and Biological Research|January 1, 1993
Hepatocellular carcinoma: pathogenetic implications of the hepatitis delta virusF Oliveri, P Colombatto, M Derenzini, et al.
Transplantation Proceedings|December 26, 2001
Usefulness of IgM anti-HCV in differential diagnosis between recurrent hepatitis C and acute rejection in liver transplant patientsP Ciccorossi, F Filipponi, F Oliveri, et al.
Molecular Pathology : MP|August 26, 1998
Hepatocyte proliferation rate is a powerful parameter for predicting hepatocellular carcinoma development in liver cirrhosisM Borzio, D Trerè, F Borzio, et al.
Journal of Viral Hepatitis|May 20, 2003
Increasing serum levels of IgM anti-HCV are diagnostic of recurrent hepatitis C in liver transplant patients with ALT flaresP Ciccorossi, F Filipponi, F Oliveri, et al.
Transplantation Proceedings|September 2, 2003
Impact of antiviral treatment on recurrence of hepatitis B virus infection and diseaseP Ciccorossi, F Filipponi, F Oliveri, et al.
The Journal of Cardiovascular Surgery|October 1, 1995
Bronchial carcinoid associated with Cushing's syndromeA Oliaro, P L Filosso, C Casadio, et al.
Progress in Clinical and Biological Research|January 1, 1991
Does HBeAg minus HBV modify the course of HDV superinfection?M R Brunetto, F Oliveri, M Baldi, et al.
Gastroenterology|September 1, 1993
Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis BM R Brunetto, M Giarin, G Saracco, et al.
The Journal of Antimicrobial Chemotherapy|June 15, 2007
Emergence of hepatitis B virus quasispecies with lower susceptibility to nucleos(t)ide analogues during lamivudine treatmentF Moriconi, P Colombatto, B Coco, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 1991
Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitisM R Brunetto, M M Giarin, F Oliveri, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Progress in Clinical and Biological Research|January 1, 1993
Hepatocellular carcinoma: pathogenetic implications of the hepatitis delta virusF Oliveri, P Colombatto, M Derenzini, et al.
Transplantation Proceedings|December 26, 2001
Usefulness of IgM anti-HCV in differential diagnosis between recurrent hepatitis C and acute rejection in liver transplant patientsP Ciccorossi, F Filipponi, F Oliveri, et al.
Molecular Pathology : MP|August 26, 1998
Hepatocyte proliferation rate is a powerful parameter for predicting hepatocellular carcinoma development in liver cirrhosisM Borzio, D Trerè, F Borzio, et al.
Journal of Viral Hepatitis|May 20, 2003
Increasing serum levels of IgM anti-HCV are diagnostic of recurrent hepatitis C in liver transplant patients with ALT flaresP Ciccorossi, F Filipponi, F Oliveri, et al.
Transplantation Proceedings|September 2, 2003
Impact of antiviral treatment on recurrence of hepatitis B virus infection and diseaseP Ciccorossi, F Filipponi, F Oliveri, et al.
The Journal of Cardiovascular Surgery|October 1, 1995
Bronchial carcinoid associated with Cushing's syndromeA Oliaro, P L Filosso, C Casadio, et al.
Progress in Clinical and Biological Research|January 1, 1991
Does HBeAg minus HBV modify the course of HDV superinfection?M R Brunetto, F Oliveri, M Baldi, et al.
Gastroenterology|September 1, 1993
Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis BM R Brunetto, M Giarin, G Saracco, et al.
The Journal of Antimicrobial Chemotherapy|June 15, 2007
Emergence of hepatitis B virus quasispecies with lower susceptibility to nucleos(t)ide analogues during lamivudine treatmentF Moriconi, P Colombatto, B Coco, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 1991
Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitisM R Brunetto, M M Giarin, F Oliveri, et al.
Pageof 7